Cargando…
Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial
BACKGROUND: Women with BRCA1/2 mutations have a higher risk of developing breast and ovarian cancer compared to women of the general population. Various preventive options are available to deal with the increased risk of developing cancer. These include intensified breast cancer screening and risk-r...
Autores principales: | Kautz-Freimuth, Sibylle, Redaèlli, Marcus, Isselhard, Anna, Shukri, Arim, Vodermaier, Andrea, Rhiem, Kerstin, Schmutzler, Rita, Stock, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848811/ https://www.ncbi.nlm.nih.gov/pubmed/35172875 http://dx.doi.org/10.1186/s13063-022-06081-7 |
Ejemplares similares
-
Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2021) -
Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2023) -
Decision Aids for Preventive Treatment Alternatives for
BRCA1/2
Mutation Carriers: a Systematic Review
por: Krassuski, Lisa Marlene, et al.
Publicado: (2021) -
Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
por: Krassuski, Lisa, et al.
Publicado: (2019) -
“You Always Have It in the Back of Your Mind”—Feelings, Coping, and Support Needs of Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling in Germany: A Qualitative Interview Study
por: Stracke, Claudia, et al.
Publicado: (2022)